REFERENCES
1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med 2010; 363(17):1597-607.
2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med2011; 364(23):2187-98.
3. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med 2019; 380(18):1706-1715.
4. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med 2019; 380(18):1695-1705.
5. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. Ann Thorac Surg 2021; 111(2):701-722.
6. Boskovski MT, Nguyen TC, Mccabe JM, et al. Outcomes of Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.JAMA Surgery 2020; 155(1):69.
7. Azraai M, Gao L, Ajani AE. Cost-Effectiveness of Transcatheter Aortic Valve Intervention (TAVI) Compared to Surgical Aortic Valve Replacement (SAVR) in Low- to Intermediate-Surgical-Risk Patients. Cardiovasc Revasc Med 2020; 21(9):1164-1168.
8. Baron SJ, Wang K, House JA, et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Circulation 2019; 139(7):877-888.
9. Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 2013; 99(13):914-20.
10. Reynolds MR, Lei Y, Wang K, et al. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement. J Am Coll Cardiol 2016; 67(1):29-38.
11. Zhou JY, Liew D, Duffy SJ, et al. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Severe Aortic Stenosis. Heart Lung Circ 2021; 30(4):547-554.
12. Tam DY, Hughes A, Fremes SE, et al. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.J Thorac Cardiovasc Surg 2018; 155(5):1978-1988.e1.
13. Manolis AS. Transcatheter aortic valve implantation economics: a grisly reality. Annals of Cardiothoracic Surgery 2017; 6(5):516-523.
14. Butala NM, Chung M, Secemsky EA, et al. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes. JACC Cardiovasc Interv 2020; 13(11):1277-1287.
15. Fröhlich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)–systematic review and meta-analysis. BMC medicine 2014; 12:41-41.
16. Mayr NP, Wiesner G, Husser O, et al. Critical adverse events during transfemoral TAVR in conscious sedation. Is an anesthesiologic support mandatory? Cardiovascular Revascularization Medicine 2018; 19(6):41-46.
17. Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med 2012; 13(4):207-10.
18. Bergmann L, Kahlert P, Eggebrecht H, et al. Transfemoral aortic valve implantation under sedation and monitored anaesthetic care–a feasibility study. Anaesthesia 2011; 66(11):977-82.
19. Brecker SJ, Bleiziffer S, Bosmans J, et al. Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study). Am J Cardiol 2016; 117(8):1332-8.
20. Kimmel J, Potosky R, Williams MR, et al. Conversion from Monitored Anesthesia Care to General Anesthesia for Transcatheter Aortic Valve Replacement. J Cardiothorac Vasc Anesth 2018; 32(2):1032-1040.
21. Kislitsina ON, Smith D, Sherwani SS, et al. Comparison of Monitored Anesthesia Care and General Anesthesia for Transcatheter Aortic Valve Replacement. Innovations (Phila) 2019; 14(5):436-444.
22. Abbett SK, Urman RD, Resor C, et al. The Impact of Anesthesia Type on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of Cardiothoracic and Vascular Anesthesia2020.
23. Thiele H, Kurz T, Feistritzer H-J, et al. General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial. Circulation 2020.
24. Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of Transfemoral Transcatheter Aortic Valve Replacement Performed in the Catheterization Laboratory (Minimalist Approach) Versus Hybrid Operating Room (Standard Approach). JACC: Cardiovascular Interventions2014; 7(8):898-904.
25. Toppen W, Johansen D, Sareh S, et al. Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up? PloS one 2017; 12(4):e0173777-e0173777.
26. Mosleh W, Mather JF, Amer MR, et al. Propensity Matched Analysis Comparing Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Implantation. Am J Cardiol 2019; 124(1):70-77.
27. Coylewright M, Forrest JK, McCabe JM, et al. TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making. J Am Coll Cardiol 2020; 75(10):1208-1211.
28. Feldman D, Romashko M, Koethe B, et al. COMORBIDITY BURDEN AND ADVERSE OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT.Journal of the American College of Cardiology 2020; 75(11):1423.
29. Hall PS, O’Donnell CI, Mathew V, et al. Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv 2019; 12(21):2186-2194.
30. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385(9986):2477-84.
31. Anantha-Narayanan M, Kandasamy VV, Reddy YN, et al. Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med 2020; 21(4):441-452.
32. Ando T, Ashraf S, Villablanca P, et al. Meta-Analysis of Effectiveness and Safety of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Low-to-Intermediate Surgical Risk Cohort. Am J Cardiol 2019; 124(4):580-585.
33. Okoh AK, Haik N, Haik B, et al. Periprocedural complications after transcatheter aortic valve replacement and their impact on resource utilization. Cardiovascular Revascularization Medicine 2020.
34. Hirji S, Mcgurk S, Kiehm S, et al. Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes. JAMA Cardiology 2020; 5(2):156.
35. Sammour Y, Kerrigan J, Banerjee K, et al. Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience.Catheter Cardiovasc Interv 2021.
36. Ahmad M, Patel JN, Vipparthy SC, et al. Conscious Sedation Versus General Anesthesia in Transcatheter Aortic Valve Replacement: A Cost and Outcome Analysis. Cureus 2019.
37. Lau W, Shannon F, Hanzel GS, et al. OUTCOME-BASED COST ANALYSIS OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT USING FASCIA ILIACA COMPARTMENT BLOCK AND MINIMALIST CONSCIOUS SEDATION APPROACH VERSUS GENERAL ANESTHESIA. Journal of the American College of Cardiology2017; 69(11):1330.
38. Patel S, Lindenberg M, Rovers MM, et al. Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room. Int J Health Policy Manag 2020.
39. Potter BJ, Ann Thompson C. Cost of operating room time for endovascular transcatheter aortic valve replacement. J Med Econ2019; 22(10):1022-1024.
40. Rong LQ, Gaudino M, Tam D, et al. Impact of operator characteristics on outcomes in transcatheter aortic valve replacement. The Annals of Thoracic Surgery 2020.
41. Carroll JD, Vemulapalli S, Dai D, et al. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes.Journal of the American College of Cardiology 2017; 70(1):29-41.
42. Khera S, Kolte D, Gupta T, et al. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement. JAMA Cardiology 2017; 2(7):732.
43. Nugent GN, Hendricks A, Nugent L, et al. Value for taxpayers’ dollars: what VA care would cost at medicare prices. Med Care Res Rev 2004; 61(4):495-508.
44. Hynes DM, Stroupe KT, Fischer MJ, et al. Comparing VA and private sector healthcare costs for end-stage renal disease. Med Care2012; 50(2):161-70.
45. Barnett PG, Hong JS, Carey E, et al. Comparison of Accessibility, Cost, and Quality of Elective Coronary Revascularization Between Veterans Affairs and Community Care Hospitals. JAMA Cardiol 2018; 3(2):133-141.